You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancers, Fatigue Trial in Houston (Psychoeducational Intervention, Open Label Placebo, Psychoeducational

Not yet recruiting
  • Metastatic Cancers
  • Fatigue
  • Psychoeducational Intervention
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Centerr
Oct 10, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (PEP07)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 1, 2023

Metastatic Prostate Cancer in Pirkanmaa Hospital District in

Not yet recruiting
  • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 17, 2023

Metastatic Castration-resistant Prostate Cancer Trial (ONCT-534)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Jun 15, 2023

Breast Cancer, Metastatic Breast Cancer, Breast Tumor Trial in Port Jefferson Station (SV-BR-1-GM, Cyclophosphamide, Interferon

Not yet recruiting
  • Breast Cancer
  • +4 more
  • SV-BR-1-GM
  • +4 more
  • Port Jefferson Station, New York
    New York Cancers & Blood Specialists
Oct 2, 2023

PROSTATE CANCER, Metastatic Prostate Cancer, Metastatic Prostate Carcinoma Trial in Boston (Supervised Circuit Training)

Not yet recruiting
  • PROSTATE CANCER
  • +2 more
  • Supervised Circuit Training
  • Boston, Massachusetts
  • +2 more
Sep 13, 2023

Discovering Factors in Metastatic Breast Cancer Patients'

Not yet recruiting
  • Metastatic Breast Cancer
    • (no location specified)
    Feb 25, 2023

    Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)

    Not yet recruiting
    • Prostatic Neoplasms
    • Metastatic Castration-Resistant Prostate Cancer
    • (no location specified)
    Nov 13, 2023

    Metastatic Hepatocellular Carcinoma Trial in Houston (Atezolizumab, Bevacizumab, ADI-PEG 20)

    Not yet recruiting
    • Metastatic Hepatocellular Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 24, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Salt Lake City, Utah
      Huntsman Cancer Institute/University of Utah
    Sep 7, 2023

    Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab

    Not yet recruiting
    • Urothelial Carcinoma
    • +2 more
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center - Philadelphia
    Jun 27, 2023

    Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))

    Not yet recruiting
    • Pancreatic Cancer Metastatic
    • C3 (Metformin, Simvastatin, and Digoxin)
    • (no location specified)
    Sep 1, 2023

    Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors Trial (INCA33890)

    Not yet recruiting
    • Solid Tumors
    • +2 more
    • (no location specified)
    Apr 26, 2023

    Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • FOLFIRINOX treatment
    • (no location specified)
    Aug 9, 2023

    Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Oct 7, 2023

    Metastatic Urothelial Carcinoma Trial in Guangzhou (utidelone injection)

    Recruiting
    • Metastatic Urothelial Carcinoma
    • utidelone injection
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    May 29, 2023

    Metastatic Microsatellite-stable Colorectal Cancer Trial (LB-100, Atezolizumab)

    Not yet recruiting
    • Metastatic Microsatellite-stable Colorectal Cancer
    • (no location specified)
    Sep 1, 2023

    Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Trial in Pittsburgh (Pembrolizumab, Carboplatin,

    Not yet recruiting
    • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Sep 18, 2023

    Metastatic Colorectal Cancer Trial in Madison (Liposomal irinotecan, TAS102, Bevacizumab)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • Liposomal irinotecan
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    May 2, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • +12 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 30, 2022

    Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

    Recruiting
    • Advanced or Metastatic Solid Tumor
    • KRAS G12C Mutation
    • Changsha, Hunan, China
      Xiangya Hospital of Central South University
    Nov 2, 2023

    Metastatic Urothelial Carcinoma Trial in Québec (Bicalutamide 150 mg, Placebo)

    Not yet recruiting
    • Metastatic Urothelial Carcinoma
    • Bicalutamide 150 mg
    • Placebo
    • Québec, Canada
      CHU de Québec - Université Laval
    Sep 6, 2023

    Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • Nanjing, Jiangsu, China
      The Affiliated Nanjing Drum Tower Hospital of Nanjing University
    Sep 18, 2023

    Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic Trial (Ivosidenib)

    Not yet recruiting
    • Cholangiocarcinoma Non-resectable
    • Cholangiocarcinoma Metastatic
    • (no location specified)
    Oct 10, 2023

    Learn More About Order of Different Treatments and Their Effects

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • Regorafenib (Stivarga, BAY73-4506)
    • (no location specified)
    Nov 13, 2023